Cancer Drug Dose Optimization Benefits Include Better Pivotal Trial Retention, Fewer Clinical Holds

 
• By Sue Sutter
Quick sand
Basing a drug development program on a shaky dose is like building a house on quicksand, OCE director Richard Pazdur says. • Source: Alamy

More from Clinical Trials

More from R&D